Bornstein SR, Allolio B, Arlt W, Barthel A, DonWauchope A, Hammer GD, et al
Which is more suitable for a patient with neuroinflammatory conditions, including anxiety, depression, and Attention Deficit Hyperactivity Disorder (ADHD), semaglutide (GLP-1 receptor agonist) or tirzepatide, considering their potential anti-inflammatory effects and safety profiles?
The research, published in the medical journal Nutrients, found that B12 and D, taken with folic acid, can reverse memory problems caused by a vitamin D deficiency
Another potential concern some individuals have noted is a change in facial appearance, often called 'Ozempic face.' This isn't caused by the medication itself but rather by the rapid weight loss that can occur
M., & Coleman, R
Nausea is the most common reason for dose adjustments, but it usually resolves within 24 weeks